Join us in-person in Lisbon, Portugal for PEGS where Just – Evotec Biologics will be presenting our science.
- Thierry Wurch, SVP Integrated Biologics Discovery and Development, Head of Antibody discovery, Evotec (France) SAS
- Nigel Shipston, Senior Director Business Development Biologics at Just-Evotec Biologics
- Leonie Enderle, Senior Research Scientist In Vitro Biology at Evotec
Presentation | Tuesday, November 14, 2023 3:40 PM
Evotec’s integrated Biologics continuum to strengthen immunotherapy discovery programs
Antibody-based Therapies track
Presented by Thierry Wurch, SVP Integrated Biologics Discovery and Development, Head of Antibody discovery, Evotec (France) SAS
Thierry WurchSVP Integrated Biologics Discovery
Thierry joined Evotec in May 2022 as SVP Integrated Biologics Discovery. He has more than 22 years of expertise in the antibody R&D space primarily in Oncology and immune-oncology. Thierry held positions of growing strategic importance from head of an antibody discovery and engineering department (Pierre Fabre, 2003-2011), head of immunotherapy discovery research activities (Servier, 2011-2017) then moving to BD-oriented activities and heading external innovation for Oncology (Servier, 2017-2020 and Ipsen 2020-2022). Thierry is also Chairman of the antibody sub-committee at NC-IUPHAR, member of the Editorial board of mAbs Journal and Distinguished Advisor of The Antibody Society.